Company
Woolsey Pharma
WOOLSEY PHARMACEUTICALS IS EXPANDING THE BOUNDARIES OF MEDICAL SCIENCE.
Also known as Woolsey Pharmaceuticals, Woolsey Pharmaceuticals, Inc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Woolsey Pharmaceuticals, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
OUR MISSION IS TO HELP USHER IN A NEW ERA OF NEURODEGENERATIVE DISEASE TREATMENT.
Funding snapshot
- Total raised
- $28.3MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Series B2025-02-27
Funding rounds
- Series B
- 2025-02-27
- Second Round of Financing
- 2021-10-01
- Round, 2021
- $19.7M2021-07-30, SEC form D sold, 41 investors
- Round, 2020
- $8.6M2020-02-18, SEC form D sold, 54 investors
Products
- Other
- BRAVYL® (oral fasudil)
Loading relationship preview